Liposomes for gene transfer and expression in vivo

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Gene therapy aims to treat diseases by introducing genetic material.
• Liposomes are effective carriers for delivering genetic material in vivo.
• Targeting specific cells within organs is crucial for efficient gene delivery.

Purpose of the Study:

• To evaluate the efficacy of liposome-encapsulated rat insulin gene for in vivo gene therapy.
• To investigate the biodistribution and cellular uptake of liposomes in rats.
• To assess the impact of liposome composition on gene transfer efficiency in liver cells.

Main Methods:

• Encapsulation of recombinant rat preproinsulin I plasmid in large liposomes.
• Intravenous injection of liposomes into rats and monitoring of glycemic and insulin levels.
• Biodistribution studies using 111In-labeled liposomes and gamma-camera imaging.
• Cellular localization of the delivered gene in liver cells (hepatocytes, Kupffer cells, endothelial cells) via Southern blotting.

Main Results:

• Liposome-delivered insulin gene significantly reduced blood glucose and increased blood, splenic, and hepatic insulin levels compared to controls.
• Liposomes were primarily taken up by spleen and liver, with uptake kinetics correlating with insulin synthesis.
• Kupffer cells were the main initial target; inclusion of lactosylceramide enhanced gene uptake in hepatocytes and endothelial cells.
• A few percent of transferred DNA was detected in liver cells, indicating high in vivo gene transfer efficiency.

Conclusions:

• Liposome-mediated delivery of the rat insulin gene is an effective in vivo gene therapy strategy.
• Liposome composition influences cellular targeting within the liver, enhancing gene transfer efficiency.
• This approach holds promise for treating conditions like diabetes through insulin gene delivery.